We are monitoring the impact of COVID-19 on Latin America Chlamydia Infection Diagnostics and Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4963
Share on
Share on

Latin America Chlamydia Infection Diagnostics and Therapeutics Market Research Report – Segmented By Product Type, End User and Country (Brazil, Argentina, Chile, Mexico and Rest of Latin America) – Industry Size, Share, Trends and Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 4963
Pages: 145

Latin America Chlamydia Infection Diagnostics and Therapeutics Market Size (2021 to 2026)

The Latin America Chlamydia Infection Diagnostics and Therapeutics market was around USD 0.29 billion in 2021. It is expected to grow at a CAGR of 6.5% to reach USD 0.39 billion by 2026. It captures 12% of the global market.

The chlamydia infection diagnostics and therapies market in Latin America has a lot of potential because of the fast-growing patient pool and large unexplored opportunities, especially in developing economies such as Latin America. Furthermore, due to the increased attention on the treatment of sexually transmitted diseases around Latin America, the market is likely to rise steadily in the near future. In addition, there is a need for improved diagnostic approaches for pelvic inflammatory illness and symptoms of chlamydial infection in women who are at high risk of tubal injury.

In Latin America, Chlamydia trachomatis is the most common sexually transmitted infection. The number of chlamydia infection diagnoses recorded continues to rise. The market for chlamydia infection therapy in Latin America is further expected to be developing as the number of sexually transmitted diseases and chlamydia cases grow. Furthermore, the market is being propelled forward by increased government measures to promote awareness about STDs and increase public knowledge about STDs.

In response to the rising economic burden of STDs, government efforts to improve awareness of STDs have intensified. An increase in government-sponsored initiatives for spreading awareness and measures such as free diagnostic camps to promote regular health check-ups are fueling the growth of the chlamydia infection treatment market. As a result, the demand for frequent health check-ups has increased, as has public awareness of the importance of sickness screening.

Despite the significance of regular STD testing, people often avoid it due to social stigma; this can result in lower screening, prevention, and care, choking the chlamydia infection treatment market's growth. In addition, patients regularly keep information about their sexual life from doctors, limiting the development of the chlamydia infection treatment market in Latin America. The market's growth is further expected to be limited by a lack of experience and understanding of laboratory settings and a lack of healthcare infrastructure. Awareness regarding chlamydia infection diagnostic tests is extremely low in nations.

This research report on the Latin America Chlamydia Infection Diagnostics and Therapeutics market has been segmented & sub-segmented into the following categories:

By Product: 

  • Diagnostics
    • Nucleic Acid Amplification Tests (NAATs)
    • Direct Fluorescent Tests
    • PCR
  • Therapeutics
    • Macrolides
    • Quinolones
    • Sulfonamides
    • Tetracycline
    • Aminopenicillins

By End User: 

  • Diagnostics
    • Hospitals
    • Specialty Clinics
    • Diagnostic Centers
  • Therapeutics
    • Hospital Pharmacies
    • Drugstores
    • Retail Pharmacies
    • Online Pharmacies

By Country: 

  • United States
  • Canada
  • Rest of North America

Geographically, it is the second-fastest-growing market but is second to last in terms of revenue generation. Brazil is the leading region in the Latin American market. Latin American region accounted for a moderate share in the global market in 2020. The acceleration in the market’s growth rate is expected due to factors such as a massive pool of potential patients, the adoption of government initiatives aimed at improving health care access, the rising frequency of chlamydia infection, improved infrastructure, and rising health care expenditure.

KEY MARKET PLAYERS:

Companies operating in the Latin America Chlamydia Infection Diagnostics and Therapeutics market profiled in this report are Bio-Rad Laboratories, Novartis AG, F Hoffmann-La Roche, Abbott Laboratories, Danaher. Other players in the market include bioMerieux, DiaSorin SpA, Siemens AG, Thermo Fisher Scientific, and Becton Dickinson and Company.

1. Introduction                                

               1.1 Market Definition                    

               1.2 Study Deliverables                  

               1.3 Base Currency, Base Year and Forecast Periods                          

               1.4 General Study Assumptions                 

2. Research Methodology                                          

               2.1 Introduction                             

               2.2 Research Phases                      

                              2.2.1 Secondary Research           

                              2.2.2 Primary Research 

                              2.2.3 Econometric Modelling      

                              2.2.4 Expert Validation  

               2.3 Analysis Design                        

               2.4 Study Timeline                         

3. Overview                                     

               3.1 Executive Summary                

               3.2 Key Inferences                         

               3.3 Epidemology                            

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

               4.1 Market Drivers                         

               4.2 Market Restraints                   

               4.3 Key Challenges                         

               4.4 Current Opportunities in the Market               

5. Market Segmentation                                            

               5.1 Product Type                            

                              5.1.1 Introduction           

                              5.1.2 Diagnostics             

                                             5.1.2.1 Nucleic Acid Amplification Tests (NAATs)

                                             5.1.2.2 Direct Fluorescent Tests

                                             5.1.2.3 PCR

                              5.1.3 Therapeutics          

                                             5.1.3.1 Macrolides

                                             5.1.3.2 Quinolones

                                             5.1.3.3 Sulfonamides

                                             5.1.3.4 Tetracycline

                                             5.1.3.5 Aminopenicillins

                              5.1.4 Y-o-Y Growth Analysis, By Product Type     

                              5.1.5 Market Attractiveness Analysis, By Product Type    

                              5.1.6 Market Share Analysis, By Product Type     

               5.2 End User                     

                              5.2.1 Introduction           

                              5.2.2 Diagnostics             

                                             5.2.2.1 Hospitals

                                             5.2.2.2 Specialty Clinics

                                             5.2.2.3 Diagnostic Centers

                              5.2.3 Therapeutics          

                                             5.2.3.1 Hospital Pharmacies

                                             5.2.3.2 Drugstores

                                             5.2.3.3 Retail Pharmacies

                                             5.2.3.4 Online Pharmacies

                              5.2.4 Y-o-Y Growth Analysis, By End User             

                              5.2.5 Market Attractiveness Analysis, By End User            

                              5.2.6 Market Share Analysis, By End User             

6. Geographical Analysis                                            

               6.1 Introduction                             

                              6.1.1 Regional Trends    

                              6.1.2 Impact Analysis     

                              6.1.3 Y-o-Y Growth Analysis        

                                             6.1.3.1 By Geographical Area

                                             6.1.3.2 By Product Type

                                             6.1.3.3 By End User

                              6.1.4  Market Attractiveness Analysis      

                                             6.1.4.1 By Geographical Area

                                             6.1.4.2 By Product Type

                                             6.1.4.3 By End User

                              6.1.5  Market Share Analysis       

                                             6.1.5.1 By Geographical Area

                                             6.1.5.2 By Product Type

                                             6.1.5.3 By End User

               6.2 Brazil                           

               6.3 Mexico                        

               6.4 Rest of Latin America                            

7. Strategic Analysis                                      

               7.1 PESTLE analysis                        

                              7.1.1 Political    

                              7.1.2 Economic 

                              7.1.3 Social        

                              7.1.4 Technological        

                              7.1.5 Legal         

                              7.1.6 Environmental       

               7.2 Porter’s Five analysis                             

                              7.2.1 Bargaining Power of Suppliers         

                              7.2.2 Bargaining Power of Consumers     

                              7.2.3 Threat of New Entrants      

                              7.2.4 Threat of Substitute Products and Services

                              7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis                                       

               8.1 Bio Rad laboratories               

                              8.1.1 Overview 

                              8.1.2 Product Analysis   

                              8.1.3 Financial analysis  

                              8.1.4 Recent Developments        

                              8.1.5 SWOT analysis       

                              8.1.6 Analyst View          

               8.2 Novartis AG               

               8.3 F Hoffmann-La Roche                           

               8.4 Abbott Laboratories               

               8.5 Danaher                      

               8.6 bioMerieux                

               8.7 DiaSorin SpA                             

               8.8 Siemens AG               

               8.9 Thermo Fisher Scientific                       

               8.10 Becton Dickinson and Company                     

9.Competitive Landscape                                           

               9.1 Market share analysis                           

               9.2 Merger and Acquisition Analysis                       

               9.3 Agreements, collaborations and Joint Ventures                          

               9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                          

               a) List of Tables                

               b) List of Figures                             

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Chlamydia Infection Diagnostics and Therapeutics Market, By Product Type, From 2021 to 2026 (USD Billion)
  2. Latin America Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  3. Latin America Therapeutics Market, By Region, From 2021 to 2026 (USD Billion)
  4. Latin America Chlamydia Infection Diagnostics and Therapeutics Market, By End User, From 2021 to 2026 (USD Billion)
  5. Latin America Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  6. Latin America Therapeutics Market, By Region, From 2021 to 2026 (USD Billion)
  7. Brazil Chlamydia Infection Diagnostics and Therapeutics Market, By Product Type, From 2021 to 2026 (USD Billion)
  8. Brazil Chlamydia Infection Diagnostics and Therapeutics Market, By End User, From 2021 to 2026 (USD Billion)
  9. Argentina Chlamydia Infection Diagnostics and Therapeutics Market, By Product Type, From 2021 to 2026 (USD Billion)
  10. Argentina Chlamydia Infection Diagnostics and Therapeutics Market, By End User, From 2021 to 2026 (USD Billion)
  11. Mexico Chlamydia Infection Diagnostics and Therapeutics Market, By Product Type, From 2021 to 2026 (USD Billion)
  12. Mexico Chlamydia Infection Diagnostics and Therapeutics Market, By End User, From 2021 to 2026 (USD Billion)
  13. Rest of Latin America Chlamydia Infection Diagnostics and Therapeutics Market, By Product Type, From 2021 to 2026 (USD Billion)
  14. Rest of Latin America Chlamydia Infection Diagnostics and Therapeutics Market, By End User, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample